Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Long-term outcomes of three-vessel coronary artery disease after coronary revascularization by percutaneous coronary intervention using second-generation drug-eluting stents versus coronary artery bypass graft surgery.

Hata R, Kubo S, Tsuneyoshi H, Shimamoto T, Kuwayama A, Ohya M, Shimada T, Miura K, Amano H, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Goto T, Komiya T, Kadota K.

Cardiovasc Interv Ther. 2020 Apr;35(2):194-202. doi: 10.1007/s12928-019-00599-5. Epub 2019 Jul 10.

PMID:
31292929
2.

Effect of combination of non-slip element balloon and drug-coating balloon for in-stent restenosis lesions (ELEGANT study).

Aoki J, Nakazawa G, Ando K, Nakamura S, Tobaru T, Sakurada M, Okada H, Hibi K, Zen K, Habara S, Fujii K, Habara M, Ako J, Asano T, Ozaki S, Fusazaki T, Kozuma K; ELEGANT Investigators.

J Cardiol. 2019 Nov;74(5):436-442. doi: 10.1016/j.jjcc.2019.04.011. Epub 2019 Jun 24.

PMID:
31248751
3.

Clinical and angiographic outcomes of true vs. false lumen stenting of coronary chronic total occlusions: Insights from intravascular ultrasound.

Sabbah M, Tada T, Kadota K, Kubo S, Otsuru S, Hasegawa D, Habara S, Tanaka H, Fuku Y, Goto T.

Catheter Cardiovasc Interv. 2019 Feb 15;93(3):E120-E129. doi: 10.1002/ccd.27861. Epub 2018 Oct 22.

PMID:
30345649
4.

Optical Coherence Tomography Predictors for Recurrent Restenosis After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.

Miura K, Tada T, Habara S, Kuwayama A, Shimada T, Ohya M, Murai R, Amano H, Kubo S, Otsuru S, Tanaka H, Fuku Y, Goto T, Kadota K.

Circ J. 2018 Oct 25;82(11):2820-2828. doi: 10.1253/circj.CJ-18-0464. Epub 2018 Aug 30.

5.

Impact of retrograde approach on long-term clinical outcomes of patients undergoing coronary chronic total occlusion interventions.

Tanaka H, Ohya M, Kubo S, Miura K, Otsuru S, Habara S, Tada T, Fuku Y, Goto T, Kadota K.

EuroIntervention. 2018 Dec 7;14(11):e1183-e1191. doi: 10.4244/EIJ-D-18-00534.

6.

In-Hospital Bleeding and Utility of a Maintenance Dose of Prasugrel 2.5 mg in High Bleeding Risk Patients With Acute Coronary Syndrome.

Ohya M, Shimada T, Osakada K, Kuwayama A, Miura K, Murai R, Amano H, Kubo S, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Goto T, Kadota K.

Circ J. 2018 Jun 25;82(7):1874-1883. doi: 10.1253/circj.CJ-18-0114. Epub 2018 Apr 26.

7.

Calcified Nodules Projecting into the Popliteal Artery Successfully Treated Through the Use of Myocardial Biopsy Forceps.

Shimada T, Goto T, Kubo S, Habara S, Tanaka H, Kadota K.

Int Heart J. 2018 May 30;59(3):660-663. doi: 10.1536/ihj.17-216. Epub 2018 May 6.

8.

Two-Year Outcomes and Predictors of Target Lesion Revascularization for Non-Left Main Coronary Bifurcation Lesions Following Two-Stent Strategy With 2nd-Generation Drug-Eluting Stents.

Ohya M, Morimoto T, Kubo S, Habara S, Kuwayama A, Miura K, Shimada T, Amano H, Otsuru S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K.

Circ J. 2018 Feb 23;82(3):798-806. doi: 10.1253/circj.CJ-17-1092. Epub 2017 Dec 19.

9.

Relationship between n-3 Polyunsaturated Fatty Acids and Extent of Vessel Disease in Patients with ST Elevation Myocardial Infarction.

Shimada T, Kadota K, Eguchi H, Osakada K, Kuwayama A, Ohya M, Miura K, Amano H, Kubo S, Ozaki M, Hyodo Y, Yoshino M, Miyake K, Kawase Y, Ohashi N, Otsuru S, Tasaka H, Habara S, Tada T, Tanaka H, Maruo T, Fuku Y, Katoh H, Fujii S, Goto T, Mitsudo K.

Int Heart J. 2017 Dec 12;58(6):868-873. doi: 10.1536/ihj.16-565. Epub 2017 Nov 17.

10.

Clinical and angiographic outcomes of axial stent deformations in unrestricted real world patient population.

Sabbah M, Kadota K, Kubo S, Hyodo Y, Otsuru S, Hasegawa D, Tada T, Habara S, Tanaka H, Fuku Y, Goto T.

J Interv Cardiol. 2017 Dec;30(6):550-557. doi: 10.1111/joic.12445. Epub 2017 Sep 20.

11.

Incidence and predictors of reCurrent restenosis after drug-coated balloon Angioplasty for Restenosis of a drUg-eluting Stent: The ICARUS Cooperation.

Cassese S, Xu B, Habara S, Rittger H, Byrne RA, Waliszewski M, Pérez-Vizcayno MJ, Gao R, Kastrati A, Alfonso F.

Rev Esp Cardiol (Engl Ed). 2018 Aug;71(8):620-627. doi: 10.1016/j.rec.2017.08.005. Epub 2017 Sep 13. Review. English, Spanish.

PMID:
28916429
12.

Effect of Intensive and Standard Pitavastatin Treatment With or Without Eicosapentaenoic Acid on Progression of Coronary Artery Calcification Over 12 Months - Prospective Multicenter Study.

Miyoshi T, Kohno K, Asonuma H, Sakuragi S, Nakahama M, Kawai Y, Uesugi T, Oka T, Munemasa M, Takahashi N, Mukohara N, Habara S, Koyama Y, Nakamura K, Ito H; PEACH Investigators.

Circ J. 2018 Jan 25;82(2):532-540. doi: 10.1253/circj.CJ-17-0419. Epub 2017 Sep 1.

13.

Impact of Dual Antiplatelet Therapy Beyond 1 Year on Clinical Outcomes of Patients With Stent Fracture or Peri-Stent Contrast Staining After Sirolimus-Eluting Stent Implantation.

Fuku Y, Kadota K, Amano H, Kubo S, Otsuru S, Habara S, Tada T, Tanaka H, Goto T.

Circ J. 2017 Dec 25;82(1):211-217. doi: 10.1253/circj.CJ-17-0477. Epub 2017 Aug 31.

14.

Very long-term serial luminal changes after sirolimus-eluting stent implantation and progression process of very late stent failure.

Kubo S, Ohya M, Kuwayama A, Shimada T, Miura K, Amano H, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K.

Cardiovasc Revasc Med. 2018 Jan - Feb;19(1 Pt B):88-94. doi: 10.1016/j.carrev.2017.06.017. Epub 2017 Jul 4.

PMID:
28778392
15.

Impact of Stent Type and Presence of Vasospastic Angina on Long-Term Prognosis.

Hata R, Oka N, Kubo S, Kuwayama A, Ohya M, Shimada T, Miura K, Amano H, Hyodo Y, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K.

Circ J. 2018 Jan 25;82(2):469-476. doi: 10.1253/circj.CJ-17-0298. Epub 2017 Jun 28.

16.

Stent Fracture and Peri-Stent Contrast Staining After Everolimus-Eluting Stent Implantation - 5-Year Outcomes.

Miura K, Tada T, Kuwayama A, Shimada T, Ohya M, Amano H, Kubo S, Hyodo Y, Otsuru S, Habara S, Tanaka H, Fuku Y, Goto T, Kadota K.

Circ J. 2017 Sep 25;81(10):1514-1521. doi: 10.1253/circj.CJ-17-0236. Epub 2017 Jun 13.

17.

A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients with small vessel disease.

Funatsu A, Nakamura S, Inoue N, Nanto S, Nakamura M, Iwabuchi M, Ando K, Asano R, Habara S, Saito S, Kozuma K, Mitsudo K.

Clin Res Cardiol. 2017 Oct;106(10):824-832. doi: 10.1007/s00392-017-1126-x. Epub 2017 Jun 6.

PMID:
28589231
18.

Difference in clinical presentations and related angiographic findings among early, late, and very late sirolimus-eluting stent failures requiring target lesion revascularization.

Kubo S, Ohya M, Kuwayama A, Shimada T, Miura K, Amano H, Hyodo Y, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K.

Int J Cardiol. 2017 Sep 15;243:116-120. doi: 10.1016/j.ijcard.2017.05.052. Epub 2017 May 13.

PMID:
28545849
19.

Long-term (8-10 years) outcomes after biodegradable polymer-coated biolimus-eluting stent implantation.

Ohya M, Kubo S, Kuwayama A, Miura K, Shimada T, Amano H, Hyodo Y, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Goto T, Kadota K.

Heart. 2017 Jul;103(13):1002-1008. doi: 10.1136/heartjnl-2016-310591. Epub 2017 Jan 17.

PMID:
28096181
20.

Late Restenosis After Both First-Generation and Second-Generation Drug-Eluting Stent Implantations Occurs in Patients With Drug-Eluting Stent Restenosis.

Habara S, Kadota K, Kuwayama A, Shimada T, Ohya M, Miura K, Amano H, Kubo S, Hyodo Y, Otsuru S, Tada T, Tanaka H, Fuku Y, Goto T.

Circ Cardiovasc Interv. 2016 Dec;9(12). pii: e004449.

PMID:
27932532
21.

Five-Year Outcomes After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.

Miura K, Kadota K, Habara S, Shimada T, Ohya M, Amano H, Kubo S, Hyodo Y, Otsuru S, Tada T, Tanaka H, Fuku Y, Goto T.

Am J Cardiol. 2017 Feb 1;119(3):365-371. doi: 10.1016/j.amjcard.2016.10.030. Epub 2016 Nov 1.

PMID:
27894569
22.

Coronary Intramural Hematoma Presenting as Acute Coronary Syndrome.

Shimada T, Kadota K, Kubo S, Habara S, Mitsudo K.

Intern Med. 2016;55(15):2025-9. doi: 10.2169/internalmedicine.55.6652. Epub 2016 Aug 1.

23.

Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [(123)I]5IA.

Matsuura Y, Ueda M, Higaki Y, Watanabe K, Habara S, Kamino S, Saji H, Enomoto S.

Nucl Med Biol. 2016 Jun;43(6):372-8. doi: 10.1016/j.nucmedbio.2016.02.007. Epub 2016 Mar 3.

PMID:
27260778
24.

Ten-year clinical outcomes after sirolimus-eluting stent implantation: Impact of an in-stent restenosis target lesion.

Miura K, Kadota K, Habara S, Miyawaki H, Shimada T, Ohya M, Amano H, Izawa Y, Hyodo Y, Otsuru S, Hasegawa D, Tada T, Tanaka H, Fuku Y, Goto T, Mitsudo K.

Am Heart J. 2016 May;175:47-55. doi: 10.1016/j.ahj.2016.02.005. Epub 2016 Feb 17.

PMID:
27179723
25.

Incidence, predictive factors, and clinical impact of stent recoil in stent fracture lesion after drug-eluting stent implantation.

Ohya M, Kadota K, Kubo S, Tada T, Habara S, Shimada T, Amano H, Izawa Y, Hyodo Y, Otsuru S, Hasegawa D, Tanaka H, Fuku Y, Goto T, Mitsudo K.

Int J Cardiol. 2016 Jul 1;214:123-9. doi: 10.1016/j.ijcard.2016.03.013. Epub 2016 Mar 25.

PMID:
27060271
26.

Stent Fracture After Sirolimus-Eluting Stent Implantation: 8-Year Clinical Outcomes.

Ohya M, Kadota K, Tada T, Habara S, Shimada T, Amano H, Izawa Y, Hyodo Y, Miyake K, Otsuru S, Hasegawa D, Tanaka H, Maruo T, Katoh H, Fuku Y, Goto T, Mitsudo K.

Circ Cardiovasc Interv. 2015 Aug;8(8):e002664. doi: 10.1161/CIRCINTERVENTIONS.115.002664.

PMID:
26227346
27.

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.

Habara S, Kadota K, Shimada T, Ohya M, Amano H, Izawa Y, Kubo S, Hyodo Y, Otsuru S, Hasegawa D, Tada T, Tanaka H, Fuku Y, Goto T, Mitsudo K.

J Am Coll Cardiol. 2015 Jul 7;66(1):14-22. doi: 10.1016/j.jacc.2015.05.002.

28.

Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.

Tada T, Kadota K, Hosogi S, Miyake K, Ohya M, Amano H, Izawa Y, Kanazawa T, Kubo S, Ichinohe T, Hyoudou Y, Hayakawa Y, Sabbah MM, Otsuru S, Hasegawa D, Habara S, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K.

Eur Heart J Cardiovasc Imaging. 2015 Oct;16(10):1101-11. doi: 10.1093/ehjci/jev031. Epub 2015 Mar 9.

PMID:
25762559
29.

Paclitaxel-coated balloon catheter compared with drug-eluting stent for drug-eluting stent restenosis in routine clinical practice.

Habara S, Kadota K, Kanazawa T, Ichinohe T, Kubo S, Hyodo Y, Otsuru S, Hasegawa D, Tada T, Tanaka H, Fuku Y, Goto T, Mitsudo K.

EuroIntervention. 2016 Feb;11(10):1098-105. doi: 10.4244/EIJY15M02_09.

30.

Everolimus-eluting stent implantation versus repeat paclitaxel-coated balloon angioplasty for recurrent in-stent restenosis lesion caused by paclitaxel-coated balloon failure.

Kubo S, Kadota K, Otsuru S, Hasegawa D, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K.

EuroIntervention. 2015 Jan;10(9):e1-8. doi: 10.4244/EIJV10I9A180.

31.

Clinical and angiographic outcomes after drug-eluting stent implantation with triple-kissing-balloon technique for left main trifurcation lesion: comparison of single-stent and multi-stent procedures.

Kubo S, Kadota K, Sabbah M, Otsuru S, Hasegawa D, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K.

J Invasive Cardiol. 2014 Nov;26(11):571-8.

32.

Low systolic blood pressure on admission predicts mortality in patients with acute decompensated heart failure due to moderate to severe aortic stenosis.

Kawase Y, Kadota K, Nakamura M, Tada T, Hata R, Miyawaki H, Kubo S, Habara S, Maruo T, Katoh H, Mitsudo K.

Circ J. 2014;78(10):2455-9. Epub 2014 Aug 26.

33.
34.

Optimal treatment of recurrent restenosis lesions after drug-eluting stent implantation for in-stent restenosis lesions.

Kubo S, Kadota K, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K.

EuroIntervention. 2013 Nov;9(7):788-96. doi: 10.4244/EIJV9I7A131.

35.

Comparison of long-term outcome after percutaneous coronary intervention for stent thrombosis between early, late, and very late stent thrombosis.

Kubo S, Kadota K, Ichinohe T, Miyake K, Hyodo Y, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Fujii S, Goto T, Mitsudo K.

Circ J. 2014;78(1):101-9. Epub 2013 Nov 2.

36.

Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty.

Tada T, Kadota K, Hosogi S, Miyake K, Amano H, Nakamura M, Izawa Y, Kubo S, Ichinohe T, Hyoudou Y, Eguchi H, Hayakawa Y, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Tanaka H, Fuku Y, Kato H, Goto T, Mitsudo K.

Eur Heart J Cardiovasc Imaging. 2014 Mar;15(3):307-15. doi: 10.1093/ehjci/jet165. Epub 2013 Sep 15.

PMID:
24042176
37.

A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.

Habara S, Iwabuchi M, Inoue N, Nakamura S, Asano R, Nanto S, Hayashi Y, Shiode N, Saito S, Ikari Y, Kimura T, Hosokawa J, Nakamura M, Kotani J, Kozuma K, Mitsudo K.

Am Heart J. 2013 Sep;166(3):527-33. doi: 10.1016/j.ahj.2013.07.002. Epub 2013 Aug 13.

PMID:
24016503
38.

Seven-year clinical outcomes of unprotected left main coronary artery stenting with drug-eluting stent and bare-metal stent.

Kubo S, Kadota K, Shimada T, Ozaki M, Ichinohe T, Eguchi H, Miyake K, Hyodo Y, Saito N, Otsuji H, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Yamamoto H, Fujii S, Goto T, Mitsudo K.

Circ J. 2013;77(10):2497-504. Epub 2013 Jun 25.

39.

Difference in clinical and angiographic characteristics of very late stent thrombosis between drug-eluting and bare-metal stent implantations.

Kubo S, Kadota K, Ozaki M, Ichinohe T, Eguchi H, Miyake K, Hyodo Y, Saito N, Otsuji H, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Yamamoto H, Fujii S, Goto T, Mitsudo K.

Circ J. 2013;77(6):1453-60. Epub 2013 Mar 26.

40.

Giant-cell myocarditis complicated by heparin-induced thrombocytopenia.

Morita J, Oka N, Kadota K, Goto T, Fujii S, Yamamoto H, Katoh H, Fuku Y, Hirono A, Maruo T, Tanaka H, Habara S, Ichinohe T, Notohara K, Mitsudo K.

Intern Med. 2012;51(22):3139-43. Epub 2012 Nov 15.

41.

Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining.

Tada T, Kadota K, Hosogi S, Kubo S, Ozaki M, Yoshino M, Miyake K, Eguchi H, Ohashi N, Hayakawa Y, Saito N, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Imai M, Tanaka H, Fuku Y, Oka N, Kato H, Yamamoto H, Fujii S, Goto T, Mitsudo K.

Circ Cardiovasc Interv. 2012 Oct;5(5):649-56. doi: 10.1161/CIRCINTERVENTIONS.112.968487. Epub 2012 Sep 25.

PMID:
23011265
42.

Serial clinical and angiographic follow-up after phosphorylcholine-coated stent implantation.

Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, Yamamoto H, Katoh H, Oka N, Fuku Y, Hosogi S, Hirono A, Maruo T, Tanaka H, Shigemoto Y, Hasegawa D, Tasaka H, Kusunose M, Otsuru S, Okamoto Y, Saito N, Tsujimoto Y.

Int Heart J. 2011;52(2):88-91.

43.

Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis.

Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, Yamamoto H, Katoh H, Oka N, Fuku Y, Hosogi S, Hirono A, Maruo T, Tanaka H, Shigemoto Y, Hasegawa D, Tasaka H, Kusunose M, Otsuru S, Okamoto Y, Saito N, Tsujimoto Y, Eguchi H, Miyake K, Yoshino M.

JACC Cardiovasc Interv. 2011 Feb;4(2):149-54. doi: 10.1016/j.jcin.2010.10.012.

44.

The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis.

Habara S, Mitsudo K, Goto T, Kadota K, Fujii S, Yamamoto H, Kato H, Takenaka S, Fuku Y, Hosogi S, Hirono A, Yamamoto K, Tanaka H, Hasegawa D, Nakamura Y, Tasaka H, Otsuru S, Okamoto Y, Yamada C, Miyamoto M, Inoue K.

Heart. 2008 Sep;94(9):1162-5. Epub 2007 Nov 21.

PMID:
18032460
45.

Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation.

Habara S, Dote K, Kato M, Sasaki S, Goto K, Takemoto H, Hasegawa D, Matsuda O.

Eur Heart J. 2007 Sep;28(18):2217-22. Epub 2007 Aug 22.

PMID:
17716991
46.

Plain computed tomography for assessment of early coronary microcirculatory damage after revascularization therapy in acute myocardial infarction.

Kato M, Dote K, Sasaki S, Ueda K, Goto K, Takemoto H, Habara S, Hasegawa D, Matsuda O, Nakano Y, Naganuma T.

Circ J. 2006 Nov;70(11):1475-80.

47.

Determination of the optimal atrioventricular interval in sick sinus syndrome during DDD pacing.

Kato M, Dote K, Sasaki S, Goto K, Takemoto H, Habara S, Hasegawa D, Matsuda O.

Pacing Clin Electrophysiol. 2005 Sep;28(9):892-7.

PMID:
16176525
48.

Myocardial performance index for assessment of left ventricular outcome in successfully recanalised anterior myocardial infarction.

Kato M, Dote K, Sasaki S, Goto K, Takemoto H, Habara S, Hasegawa D.

Heart. 2005 May;91(5):583-8.

49.

Intracoronary verapamil rapidly terminates reperfusion tachyarrhythmias in acute myocardial infarction.

Kato M, Dote K, Sasaki S, Takemoto H, Habara S, Hasegawa D.

Chest. 2004 Sep;126(3):702-8.

PMID:
15364745
50.

Clinical implications of carotid artery remodeling in acute coronary syndrome: ultrasonographic assessment of positive remodeling.

Kato M, Dote K, Habara S, Takemoto H, Goto K, Nakaoka K.

J Am Coll Cardiol. 2003 Sep 17;42(6):1026-32.

Supplemental Content

Loading ...
Support Center